Detalhe da pesquisa
1.
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.
Nature
; 569(7756): 428-432, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31043740
2.
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects.
Blood
; 138(10): 858-870, 2021 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34036317
3.
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils.
Eur J Immunol
; 51(9): 2274-2280, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33963542
4.
Radiation and Dust Sensor for Mars Environmental Dynamic Analyzer Onboard M2020 Rover.
Sensors (Basel)
; 22(8)2022 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35458893
5.
Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1.
Br J Cancer
; 124(7): 1275-1285, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33531689
6.
Intratumoral NK cell delivery combined with neutralization of the NKG2A pathway as treatment for solid cancer.
Genes Immun
; 2024 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38461213
7.
Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment.
Blood
; 127(9): 1202-5, 2016 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26738538
8.
TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.
Blood
; 128(6): 866-71, 2016 08 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27365424
9.
DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.
Blood
; 128(24): 2846-2858, 2016 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27760760
10.
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
J Immunol
; 195(1): 347-55, 2015 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25994967
11.
CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.
Blood
; 124(22): 3320-8, 2014 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-25293774
12.
Increased antitumor effects using IL-2 with anti-TGF-ß reveals competition between mouse NK and CD8 T cells.
J Immunol
; 193(4): 1709-16, 2014 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25000978
13.
Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.
Proc Natl Acad Sci U S A
; 110(18): 7401-6, 2013 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-23589894
14.
Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses.
Blood
; 122(8): 1518-21, 2013 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-23818546
15.
Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.
J Immunol
; 191(2): 688-98, 2013 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23752612
16.
Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.
Blood
; 119(6): 1590-8, 2012 Feb 09.
Artigo
Inglês
| MEDLINE | ID: mdl-22184406
17.
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C.
J Immunother Cancer
; 12(4)2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38631714
18.
Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.
Blood
; 117(26): 7032-41, 2011 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-21498673
19.
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.
EMBO Mol Med
; 15(11): e17804, 2023 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37782273
20.
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-ß antagonists.
Mol Ther Nucleic Acids
; 33: 668-682, 2023 Sep 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37650116